Alkem Laboratories Limited (NSE:ALKEM) — Stock Price

Rs5598.50 INR
▼ -0.38% today

Alkem Laboratories Limited (NSE:ALKEM) is currently trading at Rs5598.50 INR, down 0.38% today. Over the past 52 weeks, shares have ranged between Rs5144.50 and Rs5890.00. This page tracks Alkem Laboratories Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see ALKEM market cap overview.

Alkem Laboratories Limited (ALKEM) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Alkem Laboratories Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Alkem Laboratories Limited Income Statement — Revenue, Profit & Earnings by Year

Alkem Laboratories Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rs128.05 Billion Rs124.39 Billion Rs114.40 Billion Rs105.12 Billion Rs87.28 Billion
Cost of Revenue Rs48.58 Billion Rs50.32 Billion Rs49.82 Billion Rs42.83 Billion Rs35.86 Billion
Gross Profit Rs79.47 Billion Rs74.07 Billion Rs64.58 Billion Rs62.29 Billion Rs51.42 Billion
Research & Development Rs5.62 Billion Rs5.25 Billion Rs5.41 Billion Rs5.69 Billion Rs5.34 Billion
SG&A Rs3.17 Billion Rs3.03 Billion Rs2.99 Billion Rs2.48 Billion Rs2.23 Billion
Total Operating Expenses Rs57.63 Billion Rs54.23 Billion Rs51.24 Billion Rs44.60 Billion Rs34.71 Billion
Operating Income Rs21.84 Billion Rs19.85 Billion Rs13.34 Billion Rs17.69 Billion Rs16.71 Billion
EBITDA Rs29.71 Billion Rs24.18 Billion Rs17.09 Billion Rs21.89 Billion Rs21.66 Billion
EBIT Rs26.14 Billion Rs21.19 Billion Rs13.99 Billion Rs18.85 Billion Rs18.91 Billion
Interest Expense Rs1.05 Billion Rs970.80 Million Rs1.07 Billion Rs424.20 Million Rs589.20 Million
Income Before Tax Rs25.27 Billion Rs20.23 Billion Rs13.05 Billion Rs18.44 Billion Rs18.42 Billion
Income Tax Expense Rs3.11 Billion Rs2.12 Billion Rs2.98 Billion Rs1.64 Billion Rs2.24 Billion
Net Income Rs21.65 Billion Rs17.96 Billion Rs9.84 Billion Rs16.46 Billion Rs15.85 Billion

Alkem Laboratories Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Alkem Laboratories Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rs176.91 Billion Rs155.75 Billion Rs137.57 Billion Rs140.69 Billion Rs115.19 Billion
Total Current Assets Rs109.46 Billion Rs104.12 Billion Rs87.30 Billion Rs84.35 Billion Rs69.29 Billion
Cash & Equivalents Rs1.07 Billion Rs0.00 Rs747.00 Million Rs30.00 Million Rs95.40 Million
Short-term Investments Rs41.96 Billion Rs38.15 Billion Rs26.60 Billion Rs24.86 Billion Rs15.79 Billion
Net Receivables Rs24.75 Billion Rs22.85 Billion Rs23.29 Billion Rs20.69 Billion Rs28.46 Billion
Inventory Rs29.22 Billion Rs26.61 Billion Rs26.08 Billion Rs30.06 Billion Rs23.12 Billion
Property, Plant & Equipment Rs28.63 Billion Rs25.57 Billion Rs25.14 Billion Rs27.66 Billion Rs27.06 Billion
Goodwill Rs4.23 Billion Rs4.17 Billion Rs4.13 Billion Rs4.03 Billion Rs3.95 Billion
Total Liabilities Rs52.57 Billion Rs48.60 Billion Rs43.22 Billion Rs52.22 Billion Rs39.61 Billion
Total Current Liabilities Rs39.65 Billion Rs39.95 Billion Rs37.07 Billion Rs48.05 Billion Rs36.04 Billion
Long-term Debt Rs3.11 Billion Rs400.00 Million Rs0.00 Rs93.80 Million Rs342.50 Million
Net Debt Rs10.77 Billion Rs9.63 Billion Rs11.23 Billion Rs24.36 Billion Rs15.54 Billion
Total Stockholder Equity Rs119.85 Billion Rs103.12 Billion Rs90.45 Billion Rs86.38 Billion Rs73.77 Billion
Retained Earnings Rs99.73 Billion Rs83.10 Billion Rs70.52 Billion Rs65.94 Billion Rs53.67 Billion

Alkem Laboratories Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Alkem Laboratories Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rs19.13 Billion Rs19.48 Billion Rs16.82 Billion Rs11.11 Billion Rs12.65 Billion
Capital Expenditures Rs6.76 Billion Rs2.59 Billion Rs2.33 Billion Rs3.39 Billion Rs1.95 Billion
Free Cash Flow Rs12.37 Billion Rs16.89 Billion Rs14.50 Billion Rs7.72 Billion Rs10.70 Billion
Investing Cash Flow Rs-12.99 Billion Rs-10.09 Billion Rs1.13 Billion Rs-14.35 Billion Rs-9.99 Billion
Financing Cash Flow Rs-8.11 Billion Rs-11.45 Billion Rs-17.61 Billion Rs3.80 Billion Rs-2.72 Billion
Dividends Paid Rs5.05 Billion Rs5.38 Billion Rs5.30 Billion Rs4.22 Billion Rs3.35 Billion
Stock-Based Compensation Rs166.10 Million Rs189.40 Million Rs0.00 Rs0.00 Rs1.10 Million
Depreciation Rs3.57 Billion Rs2.99 Billion Rs3.10 Billion Rs3.04 Billion Rs2.75 Billion
Change in Cash Rs-1.86 Billion Rs-2.07 Billion Rs416.20 Million Rs579.60 Million Rs-17.20 Million

Alkem Laboratories Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Alkem Laboratories Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 29, 2026 — 39.25 —
Feb 13, 2026 56.88 57.97 -1.88%
Nov 13, 2025 63.99 60.55 +5.68%
Aug 12, 2025 54.62 45.80 +19.26%
May 29, 2025 25.57 29.48 -13.26%
Feb 07, 2025 52.34 51.12 +2.39%
Nov 13, 2024 58.72 55.37 +6.05%
Aug 09, 2024 45.60 34.23 +33.22%